♥

Help us fund the research needed to find new treatments for appendix cancer.

Donate

Get new posts by email

RECENT POSTS

Author: Amanda Moore

  • Renee Was 31 and Training for a Half Marathon. Ten Years Later, She’s Still Running.

    Renee Was 31 and Training for a Half Marathon. Ten Years Later, She’s Still Running.

    Renee Hill is an appendix cancer survivor who was diagnosed at 31 with stage 4B mucinous adenocarcinoma of the appendix with signet ring cells. Her cancer returned in her liver in 2020, and she has had no evidence of disease in the six years since that surgery. Renee is flying to Italy this afternoon. Ten…

  • When an Appendix Abscess Is Not Just an Abscess

    When an Appendix Abscess Is Not Just an Abscess

    Yes, an appendix abscess can be associated with an underlying appendiceal tumor. A 2025 prospective study of 370 patients with an abscess around the appendix found tumors in 14.3 percent, compared with 1.5 percent of patients with uncomplicated appendicitis. Nearly all of those tumors were in patients over 35. New imaging research published on August…

  • The Retracted Fenbendazole Study, and How to Check Papers Yourself

    The Retracted Fenbendazole Study, and How to Check Papers Yourself

    The retracted fenbendazole study that keeps circulating was pulled by its journal on January 21, 2026. It described three patients. None of them had appendix cancer. Someone sends me a fenbendazole link almost every week. It’s a dog dewormer. The claim is that it cures cancer, and the claim almost always arrives with a paper…

  • A RAS Drug Just Got Approved. Appendix Cancer Was Not on the Label

    A RAS Drug Just Got Approved. Appendix Cancer Was Not on the Label

    Short answer: On August 26, 2026, the FDA approved Rasonque (daraxonrasib), the first RAS drug approved for pancreatic cancer and the first that blocks multiple mutant forms of RAS at once. The approval covers metastatic pancreatic adenocarcinoma only. There is no approved RAS inhibitor appendix cancer patients can get today. The FDA just approved the…

  • Appendix Cancer Awareness Month States: 14 Down, 36 to Go

    Appendix Cancer Awareness Month States: 14 Down, 36 to Go

    The number of states recognizing Appendix Cancer Awareness Month went from one in 2025 to fourteen in 2026, largely because patients, caregivers, and family members decided to ask their governors. How many states recognize Appendix Cancer Awareness Month? As of August 23, 2026, fourteen states have granted August state-level recognition: Delaware, Hawaii, Idaho, Illinois, Kentucky,…

  • Appendix Cancer Treatment Update: GNAS, KRAS, and CDK4/6 Inhibitors | Dr. Andrew Lowy

    Appendix Cancer Treatment Update: GNAS, KRAS, and CDK4/6 Inhibitors | Dr. Andrew Lowy

    Short answer: Ibrance appendix cancer research has now run for ten years, and it shows that palbociclib has activity in mucinous appendiceal tumors with GNAS mutations and may slow their growth. It is not a cure. Dr. Andrew Lowy says the next step is pairing it with the new KRAS drugs, and a trial built…